Clinical trials
Phase 4 Cystitis, Interstitial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 5 |
| Unknown status | 3 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endeavor Health | 3 |
| Citrus Valley Medical Research, Inc. | 1 |
| Edgar LeClaire, MD | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| National Multiple Sclerosis Center | 1 |
| Pelvic and Sexual Health Institute | 1 |
| Radboud University Medical Center | 1 |
| Shirley Ryan AbilityLab | 1 |
| State University of New York at Buffalo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cystitis, Interstitial | 19 |
| Pelvic Pain | 3 |
| Urinary Bladder, Overactive | 3 |
| Agnosia | 1 |
| Chronic Pain | 1 |
| Colitis, Ulcerative | 1 |
| Constipation | 1 |
| Dysmenorrhea | 1 |
| Dyspareunia | 1 |
| Endometriosis | 1 |
Trials
Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.